We are live on ! Find out more
VRNA

Verona Pharma

Delisted

VRNA was delisted on the 6th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$38.3M
NMC
2
NEA Management Company
Maryland
$34.3M
RCM
3
RA Capital Management
Massachusetts
$34.3M
Wellington Management Group
4
Wellington Management Group
Massachusetts
$32.5M +$2.75M +537,950 +13%
PA
5
Perceptive Advisors
New York
$19.3M -$109K -21,379 -0.7%
VC
6
Vivo Capital
California
$18.5M
A
7
Abingworth
United Kingdom
$16.3M
ACM
8
Aisling Capital Management
New York
$8.95M
FCMI
9
Foresite Capital Management III
California
$7.47M
SB
10
Samsara BioCapital
California
$7.47M
FFM
11
Fairmount Funds Management
Pennsylvania
$6.23M
SFM
12
Sphera Funds Management
Israel
$5.38M
NHAS
13
Novo Holdings A/S
Denmark
$5.12M
TCM
14
Tekla Capital Management
Massachusetts
$5.05M
GTC
15
Ghost Tree Capital
New York
$5.04M
VP
16
venBio Partners
California
$1.09M
LGM
17
Logos Global Management
California
$820K +$623K +122,000 New
SSA
18
Schonfeld Strategic Advisors
New York
$390K -$3.06K -600 -1%
DADC
19
D.A. Davidson & Co
Montana
$323K +$40.9K +8,000 +20%
FA
20
Forefront Analytics
Pennsylvania
$229K +$4.85K +950 +3%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$207K +$78.8K +15,416 +100%
Millennium Management
22
Millennium Management
New York
$107K +$6.04K +1,183 +8%
HSBC Holdings
23
HSBC Holdings
United Kingdom
$102K
Geode Capital Management
24
Geode Capital Management
Massachusetts
$89K +$13.1K +2,566 +24%
Marshall Wace
25
Marshall Wace
United Kingdom
$82K +$62.6K +12,263 New